The FTSE 100 closed sharply lower on Friday, 6 November, as global stock markets remained under pressure following a steep sell-off in US technology shares. The FTSE 100 finished down
The FTSE 100 closed sharply lower on Friday, 6 November, as global stock markets remained under pressure following a steep sell-off in US technology shares. The FTSE 100 finished down
MedPal AI plc (AIM: MPAL; FRA: Z1N) has reported strong October trading, with group revenue climbing to approximately £4.1 million as its New Health weight management business recorded a sharp
MedPal AI plc (AIM: MPAL) has announced that its New Health business has become one of the UK’s top 30 Mounjaro providers by supply volume, climbing from 3,048th to 29th
The FTSE 100 closed 1.06% higher at 10,552.05 on Friday, while the FTSE 250 gained 1.13% to 24,213.78. The rebound followed a volatile week dominated by oil prices, inflation concerns
MedPal AI plc (AIM: MPAL; FRA: Z1N) has issued a trading and financing update following sharp movements in its share price and trading volumes.
MedPal AI plc (AIM: MPAL; FRA: Z1N) reported another sharp increase in trading during September, with Group revenue reaching £3.2 million.
MedPal AI plc (AIM: MPAL; FRA: Z1N) has appointed former eEnergy Group chief executive Harvey Sinclair as an independent non-executive director as the digital health group looks to strengthen its
The Times: Mounting costs are damaging business investment and undermining the government’s attempts to raise living standards, the Confederation of British Industry has warned. Ahead of John Healey’s first major economic
MedPal AI plc (AIM: MPAL) has reported a sharp acceleration in trading, with its New Health GLP-1 weight-management business generating £1.83 million of revenue in August, an increase of more
Kendrick Resources (KEN) announced a further important validation milestone at the Teufelskuppe (“TK”) Project, where X-ray fluorescence (“pXRF”) measurements of Light Rare Earth Oxide (“LREO”) grades in drill core have demonstrated an exceptionally strong positive correlation with
MedPal AI plc (AIM: MPAL) has highlighted the potential expansion of the GLP-1 market after the US Food and Drug Administration approved Eli Lilly’s Mounjaro to reduce the risk of
The FTSE 100 extended its losing streak to a fifth consecutive session on Friday, falling 22.56 points, or 0.2%, to close at 10,750.11, as weakness among miners and pharmaceutical heavyweights